Sign in or create an account to add this stock to your watchlist.
About Fulgent Genetics (NASDAQ:FLGT)
Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It markets its tests through internal sales force, as well as through independent sales representatives in the United States, Canada, the People's Republic of China, and internationally. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Industry, Sector and Symbol
Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:FLGT
CUSIPN/A
Phone626-350-0537
Debt
Debt-to-Equity RatioN/A
Current Ratio15.03
Quick Ratio15.03
Price-To-Earnings
Trailing P/E Ratio-34.00
Forward P/E Ratio-12.90
P/E GrowthN/A
Sales & Book Value
Annual Sales$18.73 million
Price / Sales3.57
Cash Flow$0.0035 per share
Price / Cash1,076.44
Book Value$2.96 per share
Price / Book1.26
Profitability
EPS (Most Recent Fiscal Year)($0.11)
Net Income$-2,510,000.00
Net Margins-26.57%
Return on Equity-7.62%
Return on Assets-7.22%
Miscellaneous
Employees98
Outstanding Shares17,890,000
Fulgent Genetics (NASDAQ:FLGT) Frequently Asked Questions
What is Fulgent Genetics' stock symbol?
Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."
How were Fulgent Genetics' earnings last quarter?
Fulgent Genetics (NASDAQ:FLGT) issued its earnings results on Monday, May, 7th. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.02. The firm earned $4.65 million during the quarter. Fulgent Genetics had a negative return on equity of 7.62% and a negative net margin of 26.57%. View Fulgent Genetics' Earnings History.
When is Fulgent Genetics' next earnings date?
What price target have analysts set for FLGT?
2 brokers have issued 12 month target prices for Fulgent Genetics' shares. Their forecasts range from $5.00 to $7.00. On average, they expect Fulgent Genetics' share price to reach $6.00 in the next year. View Analyst Ratings for Fulgent Genetics.
Who are some of Fulgent Genetics' key competitors?
Who are Fulgent Genetics' key executives?
Fulgent Genetics' management team includes the folowing people:
- Mr. Ming Hsieh, Chairman, Chief Exec. Officer, Pres and Mang. of Fulgent LLC (Age 62)
- Mr. Paul Kim, Chief Financial Officer (Age 51)
- Dr. Han Lin Gao M.D., Ph.D., D.A.B.M.G., F.A.C.M.G., Chief Scientific Officer and Lab Director (Age 51)
- Joe Roach, VP
When did Fulgent Genetics IPO?
(FLGT) raised $60 million in an IPO on Thursday, September 29th 2016. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Credit Suisse and Piper Jaffray acted as the underwriters for the IPO and Raymond James and BTIG were co-managers.
Has Fulgent Genetics been receiving favorable news coverage?
Media headlines about FLGT stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Fulgent Genetics earned a media sentiment score of 0.23 on Accern's scale. They also assigned press coverage about the company an impact score of 45.29 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
Who are Fulgent Genetics' major shareholders?
Fulgent Genetics' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Old West Investment Management LLC (1.95%) and Dimensional Fund Advisors LP (0.15%). Company insiders that own Fulgent Genetics stock include Ming Hsieh and Paul Kim. View Institutional Ownership Trends for Fulgent Genetics.
Which institutional investors are buying Fulgent Genetics stock?
How do I buy shares of Fulgent Genetics?
Shares of FLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Fulgent Genetics' stock price today?
One share of FLGT stock can currently be purchased for approximately $3.74.
How big of a company is Fulgent Genetics?
Fulgent Genetics has a market capitalization of $68.07 million and generates $18.73 million in revenue each year. The company earns $-2,510,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis. Fulgent Genetics employs 98 workers across the globe.
How can I contact Fulgent Genetics?
Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. The company can be reached via phone at 626-350-0537 or via email at [email protected]
MarketBeat Community Rating for Fulgent Genetics (FLGT)
MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. Vote "Outperform" if you believe FLGT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FLGT will underperform the S&P 500 over the long term. You may vote once every thirty days.
Fulgent Genetics (NASDAQ:FLGT) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
2 Wall Street analysts have issued ratings and price targets for Fulgent Genetics in the last 12 months. Their average twelve-month price target is $6.00, suggesting that the stock has a possible upside of 60.43%. The high price target for FLGT is $7.00 and the low price target for FLGT is $5.00. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.50 | 2.50 | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $6.00 | $6.50 | $7.25 | $7.25 |
| Price Target Upside: | 60.43% upside | 35.70% upside | 79.01% upside | 79.01% upside |
Fulgent Genetics (NASDAQ:FLGT) Consensus Price Target History
Fulgent Genetics (NASDAQ:FLGT) Analyst Ratings History
Show:
(Data available from 5/24/2016 forward)
Fulgent Genetics (NASDAQ:FLGT) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Fulgent Genetics (NASDAQ FLGT) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 58.80%
Institutional Ownership Percentage: 7.35%
Fulgent Genetics (NASDAQ FLGT) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/14/2018 | Paul Kim | CFO | Sell | 1,370 | $3.72 | $5,096.40 | 384,031 |  |
| 3/8/2018 | Paul Kim | CFO | Sell | 1,628 | $3.76 | $6,121.28 | 385,401 | |
| 11/30/2017 | Ming Hsieh | Insider | Buy | 2,000 | $3.60 | $7,200.00 | 6,549,707 | |
| 11/20/2017 | Ming Hsieh | CEO | Buy | 7,259 | $3.28 | $23,809.52 | 6,540,849 | |
| 11/16/2017 | Ming Hsieh | Insider | Buy | 2,205 | $3.23 | $7,122.15 | 6,540,849 | |
| 11/14/2017 | Ming Hsieh | Insider | Buy | 10,504 | $3.30 | $34,663.20 | | |
| 11/13/2017 | Paul Kim | CFO | Sell | 1,573 | $3.22 | $5,065.06 | | |
| 11/9/2017 | Ming Hsieh | CEO | Buy | 11,520 | $3.47 | $39,974.40 | 6,506,464 | |
| 8/11/2017 | Paul Kim | CFO | Sell | 6,134 | $5.71 | $35,025.14 | 388,602 | |
| 6/15/2017 | Ming Hsieh | Insider | Buy | 20,000 | $5.26 | $105,200.00 | 6,482,244 | |
| 6/13/2017 | Ming Hsieh | Insider | Buy | 30,000 | $4.98 | $149,400.00 | 6,459,944 | |
| 9/30/2016 | Ming Hsieh | Insider | Buy | 1,000,000 | $9.00 | $9,000,000.00 | | |
(Data available from 1/1/2013 forward)
Fulgent Genetics (NASDAQ FLGT) News Headlines
| Source: |
|
Fulgent Genetics (NASDAQ:FLGT) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Fulgent Genetics (NASDAQ:FLGT) Income Statement, Balance Sheet and Cash Flow Statement
Fulgent Genetics (NASDAQ FLGT) Stock Chart for Thursday, May, 24, 2018
Loading chart…
